Seguir
Chih-ho Hong
Chih-ho Hong
Clinical Assistant Professor, University of British Columbia
Dirección de correo verificada de mail.ubc.ca
Título
Citado por
Citado por
Año
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded …
A Blauvelt, M de Bruin-Weller, M Gooderham, JC Cather, J Weisman, ...
The Lancet 389 (10086), 2287-2303, 2017
11732017
A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee
N Solish, V Bertucci, A Dansereau, HCH Hong, C Lynde, M Lupin, ...
Dermatologic Surgery 33 (8), 908-923, 2007
5212007
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double …
E Guttman-Yassky, HD Teixeira, EL Simpson, KA Papp, AL Pangan, ...
The Lancet 397 (10290), 2151-2168, 2021
3632021
Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial
E Guttman-Yassky, D Thaçi, AL Pangan, HC Hong, KA Papp, K Reich, ...
Journal of Allergy and Clinical Immunology 145 (3), 877-884, 2020
3292020
Dupilumab: a review of its use in the treatment of atopic dermatitis
MJ Gooderham, HC Hong, P Eshtiaghi, KA Papp
Journal of the American Academy of Dermatology 78 (3), S28-S36, 2018
3052018
Clinical evaluation of a microwave device for treating axillary hyperhidrosis
CHH Hong, M Lupin, KF O'Shaughnessy
Dermatologic surgery 38 (5), 728-735, 2012
1432012
The temperamental characteristics of Chinese babies
C Hsu, W Soong, JW Stigler, C Hong, C Liang
Child Development, 1337-1340, 1981
1431981
A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized …
A Blauvelt, K Papp, A Gottlieb, A Jarell, K Reich, C Maari, KB Gordon, ...
British journal of dermatology 182 (6), 1348-1358, 2020
1292020
Phase 3 trials of tapinarof cream for plaque psoriasis
MG Lebwohl, L Stein Gold, B Strober, KA Papp, AW Armstrong, J Bagel, ...
New England Journal of Medicine 385 (24), 2219-2229, 2021
1242021
Efficacy and safety of upadacitinib in patients with moderate to severe atopic dermatitis: analysis of follow-up data from the measure up 1 and measure up 2 randomized clinical …
EL Simpson, KA Papp, A Blauvelt, CY Chu, HC Hong, N Katoh, ...
JAMA dermatology 158 (4), 404-413, 2022
1182022
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
K Reich, JP Thyssen, A Blauvelt, K Eyerich, W Soong, ZP Rice, HC Hong, ...
The Lancet 400 (10348), 273-282, 2022
992022
Efficacy and safety of topical WBI‐1001 in patients with mild to severe atopic dermatitis: results from a 12‐week, multicentre, randomized, placebo‐controlled double‐blind trial
R Bissonnette, Y Poulin, Y Zhou, J Tan, HC Hong, J Webster, W Ip, L Tang, ...
British Journal of Dermatology 166 (4), 853-860, 2012
962012
Treat-to-target in atopic dermatitis: an international consensus on a set of core decision points for systemic therapies
M De Bruin-Weller, T Biedermann, R Bissonnette, M Deleuran, P Foley, ...
Acta Dermato-Venereologica 101 (2), 2021
702021
Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO‐INSIGHTFUL …
CH Hong, KA Papp, KW Lophaven, P Skallerup, S Philipp
Journal of the European Academy of Dermatology and Venereology 31 (11), 1876 …, 2017
532017
Efficacy and safety of guselkumab, administered with a novel patient-controlled injector (One-Press), for moderate-to-severe psoriasis: results from the phase 3 ORION study
LK Ferris, E Ott, J Jiang, HCH Hong, S Li, C Han, W Baran
Journal of Dermatological Treatment, 2019
522019
Review of systemic treatment options for adult atopic dermatitis
M Gooderham, CW Lynde, K Papp, M Bourcier, L Guenther, W Gulliver, ...
Journal of cutaneous medicine and surgery 21 (1), 31-39, 2017
512017
Optimizing the use of topical brimonidine in rosacea management: panel recommendations.
EA Tanghetti, JM Jackson, KT Belasco, A Friedrichs, F Hougier, ...
Journal of Drugs in Dermatology: JDD 14 (1), 33-40, 2015
492015
Using the internet to assess and teach medical students in dermatology
C Hong, D McLean, J Shapiro, H Lui
Journal of Cutaneous Medicine and Surgery: Incorporating Medical and …, 2002
492002
Long-term efficacy and quality of life assessment for treatment of axillary hyperhidrosis with a microwave device
M Lupin, HCH Hong, KF O'Shaughnessy
Dermatologic Surgery 40 (7), 805-807, 2014
472014
Approach to the assessment and management of adult patients with atopic dermatitis: a consensus document. Section II: tools for assessing the severity of atopic dermatitis
MJ Gooderham, R Bissonnette, P Grewal, P Lansang, KA Papp, C Hong
Journal of Cutaneous Medicine and Surgery 22 (1_suppl), 10S-16S, 2018
452018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20